Maine has joined a growing number of states that prohibit the performance of a pelvic examination on an anesthetized or unconscious patient without the oral or written informed consent specific to the pelvic examination by the patient or a patient representative. The proposed Maine legislation will also include rectal and prostate exams. Emergency situations are exempt from consent. Exceptions are made for medically necessary diagnostic or treatment purposes when the patient requires immediate medical attention and an attempt to secure consent would delay treatment, thus increasing risk to the patient’s life or health.
New York, Maryland, Utah, and Delaware have passed similar laws in 2019. In addition, California, Hawaii, Illinois, Iowa, Oregon and Virginia have made this practice illegal with more states on the way.
In 2011 (reaffirmed in 2017), ACOG released a committee opinion that states explicitly
Pelvic examinations on an anesthetized woman that offer her no personal benefit and are performed solely for teaching purposes should be performed only with her specific informed consent obtained before her surgery.
APGO: Consent for the Pelvic Examination Under Anesthesia by Medical Students.
States Move to Protect Anesthetized Women from Non-Consensual Pelvic Exams
Please sign up or log in to your ObGFirst to access this Premium Content
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
